2nd Quarter - Report

FABIANI & COMPANY for TRIUS THERAPEUTICS

Period 2nd Quarter 2010 Filed Jul 20, 2010 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
TRIUS THERAPEUTICS
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Antibiotics, BioDefense

LobbyistCovered position, as disclosed
WENDY SHELTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.